ChemoCentryx, Inc. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
ChemoCentryx, Inc. reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$70.26 million for the 6-month period ending 2022-06-30, per its 10-Q filed 2022-08-08.
Discontinued › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2022-08-08
- ChemoCentryx, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2022-06-30 was -$31.65M.
- ChemoCentryx, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2022-03-31 was -$38.61M.
- ChemoCentryx, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2021-12-31 was -$40.53M.
- ChemoCentryx, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2021-09-30 was -$22.31M.
- ChemoCentryx, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2021 was -$131.75M.
- ChemoCentryx, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2020 was -$55.36M.
- ChemoCentryx, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2019 was -$55.49M.
- ChemoCentryx, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2018 was -$37.97M, a 312.59% decline from fiscal 2017.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2022-06-30 | -$31.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$70.26M 10-Q · filed 2022-08-08 | -$110.79M derived: sum of 3 quarters · filed 2022-08-08 | -$133.09M derived: sum of 4 quarters · filed 2022-08-08 |
| 2022-03-31 | -$38.61M 10-Q · filed 2022-05-10 | -$79.14M derived: sum of 2 quarters · filed 2022-05-10 | -$101.44M derived: sum of 3 quarters · filed 2022-05-10 | -$140.65M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-12-31 | -$40.53M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$62.84M derived: sum of 2 quarters · filed 2022-03-01 | -$102.04M derived: sum of 3 quarters · filed 2022-08-08 | -$131.75M 10-K · filed 2022-03-01 |
| 2021-09-30 | -$22.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$61.52M derived: sum of 2 quarters · filed 2022-08-08 | -$91.23M 10-Q · filed 2021-11-09 | -$121.10M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-06-30 | -$39.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$68.92M 10-Q · filed 2022-08-08 | -$98.80M derived: sum of 3 quarters · filed 2022-08-08 | -$122.86M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | -$29.71M 10-Q · filed 2022-05-10 | -$59.59M derived: sum of 2 quarters · filed 2022-05-10 | -$83.65M derived: sum of 3 quarters · filed 2022-05-10 | -$63.38M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | -$29.88M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$53.94M derived: sum of 2 quarters · filed 2022-03-01 | -$33.67M derived: sum of 3 quarters · filed 2022-03-01 | -$55.36M 10-K · filed 2022-03-01 |
| 2020-09-30 | -$24.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$3.79M derived: sum of 2 quarters · filed 2021-11-09 | -$25.48M 10-Q · filed 2021-11-09 | -$41.01M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $20.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$1.42M 10-Q · filed 2021-08-09 | -$16.95M derived: sum of 3 quarters · filed 2022-03-01 | -$29.81M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | -$21.69M 10-Q · filed 2021-05-03 | -$37.22M derived: sum of 2 quarters · filed 2022-03-01 | -$50.08M derived: sum of 3 quarters · filed 2022-03-01 | -$65.23M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | -$15.53M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$28.39M derived: sum of 2 quarters · filed 2022-03-01 | -$43.54M derived: sum of 3 quarters · filed 2022-03-01 | -$55.49M 10-K · filed 2022-03-01 |
| 2019-09-30 | -$12.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$28.01M derived: sum of 2 quarters · filed 2020-11-09 | -$39.96M 10-Q · filed 2020-11-09 | -$50.75M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | -$15.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$27.10M 10-Q · filed 2020-08-10 | -$37.88M derived: sum of 3 quarters · filed 2021-03-01 | -$48.77M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | -$11.95M 10-Q · filed 2020-05-11 | -$22.73M derived: sum of 2 quarters · filed 2021-03-01 | -$33.62M derived: sum of 3 quarters · filed 2021-03-01 | -$40.50M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | -$10.79M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$21.68M derived: sum of 2 quarters · filed 2021-03-01 | -$28.55M derived: sum of 3 quarters · filed 2021-03-01 | -$37.97M 10-K · filed 2021-03-01 |
| 2018-09-30 | -$10.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | -$17.76M derived: sum of 2 quarters · filed 2019-11-04 | -$27.18M 10-Q · filed 2019-11-04 | $12.47M derived: sum of 4 quarters · filed 2020-03-10 |
| 2018-06-30 | -$6.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | -$16.29M 10-Q · filed 2019-08-05 | $23.36M derived: sum of 3 quarters · filed 2020-03-10 | $16.80M derived: sum of 4 quarters · filed 2020-03-10 |
| 2018-03-31 | -$9.42M 10-Q · filed 2019-05-06 | $30.24M derived: sum of 2 quarters · filed 2020-03-10 | $23.68M derived: sum of 3 quarters · filed 2020-03-10 | |
| 2017-12-31 | $39.66M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $33.09M derived: sum of 2 quarters · filed 2020-03-10 | $17.86M 10-K · filed 2020-03-10 | |
| 2017-09-30 | -$6.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$21.80M 10-Q · filed 2018-11-08 | ||
| 2017-06-30 | -$15.24M 10-Q · filed 2018-08-09 | |||
| 2016-12-31 | -$39.96M 10-K · filed 2019-03-11 |